ストックスクリーナーアプリを入手
125.55
5.67%
-7.545
前日終値:
$133.09
開ける：
$129.24
24時間の取引高:
1.60M
Relative Volume:
1.28
時価総額：
$9.78B
収益：
-
当期純損益:
$-159.39M
株価収益率:
-35.46
EPS:
-3.5401
ネットキャッシュフロー:
$-105.22M
1週間 パフォーマンス:
+9.64%
1か月 パフォーマンス:
+21.38%
6か月 パフォーマンス:
+1,688%
1年 パフォーマンス:
+1,541%
1日の値動き範囲:
$122.81
$131.02
1週間の範囲:
$113.79
$138.49
52週間の値動き範囲:
$4.77
$138.49
Abivax Adr Stock (ABVX) Company Profile
ABVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
125.55 | 10.37B | 0 | -159.39M | -105.22M | -3.5401 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-11-06 | 開始されました | Wolfe Research | Outperform |
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-07-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-20 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-12-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-07-29 | 開始されました | Laidlaw | Buy |
| 2024-05-20 | 開始されました | BTIG Research | Buy |
| 2024-04-29 | 開始されました | Guggenheim | Buy |
| 2024-04-29 | 開始されました | Piper Sandler | Overweight |
| 2023-11-14 | 開始されました | Leerink Partners | Outperform |
| 2023-11-14 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Abivax Adr (ABVX) 最新ニュース
A Look at Abivax ADR (ABVX) Shares in the Recent Past Indicates Growth - setenews.com
What's Happening With French Biotech Abivax Stock On Wednesday? - Benzinga
Stempoint Capital LP Invests $671,000 in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Acquired by Kennedy Capital Management LLC - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Affinity Asset Advisors LLC - MarketBeat
A3EWCP Stock Price and Chart — LSX:A3EWCP - TradingView
Abivax SA Sponsored ADR $ABVX Shares Bought by Saturn V Capital Management LP - MarketBeat
Quadrature Capital Ltd Acquires Shares of 19,367 Abivax SA Sponsored ADR $ABVX - MarketBeat
Investors in cash trouble should check out Abivax ADR (ABVX) - setenews.com
Abivax SA Sponsored ADR Dividends – LS:A3EWCP - TradingView
ETFs Investing in Abivax SA Sponsored ADR Stocks - TradingView
There is no doubt that Abivax ADR (ABVX) ticks all the boxes. - Setenews
Abivax SA Sponsored ADR (ABVX) Receives a New Rating from Truist Financial - The Globe and Mail
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of “Buy” from Analysts - Defense World
Abivax (NASDAQ:ABVX) Sees Large Volume IncreaseHere's Why - MarketBeat
Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025 - ts2.tech
Is Abivax ADR (ABVX) positioned for future growth? - Setenews
Nothing is Better Than Kyivstar Group Ltd (KYIV) stock at the moment - Setenews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
Abivax (NASDAQ:ABVX) Sets New 12-Month HighStill a Buy? - MarketBeat
Abivax (NASDAQ:ABVX) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's What You Should Know - MSN
Are Medical Stocks Lagging Abivax SA Sponsored ADR (ABVX) This Year? - sharewise.com
A new trading data show Abivax ADR (ABVX) is showing positive returns. - Setenews
Akebia Therapeutics (AKBA) Receives a Buy from BTIG - The Globe and Mail
Abivax (NASDAQ:ABVX) Sets New 52-Week HighShould You Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), ALX Oncology Holdings (ALXO) and Cencora (COR) - The Globe and Mail
Get in on Abivax ADR’s (ABVX) buy-in window today! - Setenews
Wall Street analysts’ outlook for Zevia PBC (ZVIA) - Setenews
Positive Outlook for Abivax SA: Obefazimod’s Potential in Crohn’s Disease Drives Buy Rating - TipRanks
What is Abivax ADR (ABVX) Stock Return on Shareholders’ Capital? - Setenews
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Sees Significant Decrease in Short Interest - MarketBeat
Leerink Partnrs Analysts Raise Earnings Estimates for Abivax - Defense World
Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst - The Globe and Mail
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Abivax Shares Surge After Strong Phase 3 Results in Ulcerative Colitis Study - MSN
Top 1% Biotech Abivax Surges On 'Compelling' Results In A Highly Watched Disease - Investor's Business Daily
FY2025 EPS Estimates for Abivax Boosted by Lifesci Capital - Defense World
Abivax SA Reports Financial Results and Strategic Advances - MSN
Abivax Reports Increased Losses but Secures Major Funding in H1 2025 - msn.com
Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Up 42.1% in August - MarketBeat
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), KalVista Pharmaceuticals (KALV) and Argenx Se (ARGX) - The Globe and Mail
Abivax SA Sponsored ADR (NASDAQ:ABVX) Sees Significant Increase in Short Interest - Defense World
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives $95.14 Consensus PT from Brokerages - MarketBeat
Abivax (NASDAQ:ABVX) Shares Gap Down – What’s Next? - Defense World
Octagon Capital Advisors LP Makes New $7.69 Million Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Down 38.0% in August - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Rating of “Buy” by Brokerages - Defense World
Abivax Adr (ABVX) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):